The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues
- 1 October 1993
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 24 (10) , 1073-1077
- https://doi.org/10.1016/0046-8177(93)90186-k
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomasAmerican Journal of Obstetrics and Gynecology, 1991
- Histopathological changes in leiomyomata treated with leuprolide acetateFertility and Sterility, 1990
- Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: The estrogen threshold hypothesisAmerican Journal of Obstetrics and Gynecology, 1990
- Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-upFertility and Sterility, 1989
- A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomataFertility and Sterility, 1989
- Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormoneFertility and Sterility, 1987
- Endometrial morphology after 6 months of continuous treatment with a new gonadotropin-releasing hormone superagonist for contraceptionFertility and Sterility, 1987
- GOSERELIN THERAPY BEFORE SURGERY FOR UTERINE FIBROIDSThe Lancet, 1987
- Synthetic progestogen-oestrogen therapy and uterine changesJournal of Clinical Pathology, 1967
- Induction of degenerative changes in uterine myomas by high-dosage progestin therapyAmerican Journal of Obstetrics and Gynecology, 1966